Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominick J Angiolillo

Showing results (431-440 of 760) with videos related to

Pageof 76
Sort By:
Journal of the American College of Cardiology|September 11, 2024
Genotype-Guided Antiplatelet Therapy: JACC Review Topic of the WeekWout W A van den Broek, Brenden S Ingraham, Naveen L Pereira, et al.
The American Journal of Cardiology|June 14, 2008
Impact of stent deployment procedural factors on long-term effectiveness and safety of sirolimus-eluting stents (final results of the multicenter prospective STLLR trial)Marco A Costa, Dominick J Angiolillo, Mark Tannenbaum, et al.
The International Journal of Cardiovascular Imaging|June 2, 2007
Angiographic and 3D intravascular ultrasound assessment of overlapping bare metal stent and three different formulations of drug-eluting stents in patients with diabetes mellitusRen Kawaguchi, Manel Sabate, Dominick J Angiolillo, et al.
International Journal of Cardiology|September 8, 2009
Use of Impella Recover LP 2.5 in elective high risk percutaneous coronary interventionJosé Luis Ferreiro, Joan Antoni Gómez-Hospital, Ángel R Cequier, et al.
Revista Espanola De Cardiologia|December 25, 2004
[Predictors of mortality following rescue percutaneous intervention]Pilar Jiménez-Quevedo, Manel Sabaté, Dominick J Angiolillo, et al.
Journal of the American College of Cardiology|March 13, 2010
Impact of chronic kidney disease on platelet function profiles in diabetes mellitus patients with coronary artery disease taking dual antiplatelet therapyDominick J Angiolillo, Esther Bernardo, Davide Capodanno, et al.
Journal of Cardiovascular Translational Research|December 21, 2013
Impact of cigarette smoking on P2Y12 receptor binding activity before and after clopidogrel therapy in patients with coronary artery diseaseJung Rae Cho, Bhaloo Desai, Michael J Haas, et al.
Journal of the American College of Cardiology|January 17, 2017
Enteric Coating and Aspirin Nonresponsiveness in Patients With Type 2 Diabetes MellitusDeepak L Bhatt, Tilo Grosser, Jing-Fei Dong, et al.
European Heart Journal|January 22, 2011
A pharmacodynamic comparison of prasugrel vs. high-dose clopidogrel in patients with type 2 diabetes mellitus and coronary artery disease: results of the Optimizing anti-Platelet Therapy In diabetes MellitUS (OPTIMUS)-3 TrialDominick J Angiolillo, Juan Jose Badimon, Jorge F Saucedo, et al.
American Heart Journal|January 24, 2007
Anatomical and physiologic assessments in patients with small coronary artery disease: final results of the Physiologic and Anatomical Evaluation Prior to and After Stent Implantation in Small Coronary Vessels (PHANTOM) trialMarco A Costa, Manel Sabate, Rodolfo Staico, et al.
Pageof 76

Showing results (431-440 of 760) with videos related to

Sort By:
Pageof 76
Journal of the American College of Cardiology|September 11, 2024
Genotype-Guided Antiplatelet Therapy: JACC Review Topic of the WeekWout W A van den Broek, Brenden S Ingraham, Naveen L Pereira, et al.
The American Journal of Cardiology|June 14, 2008
Impact of stent deployment procedural factors on long-term effectiveness and safety of sirolimus-eluting stents (final results of the multicenter prospective STLLR trial)Marco A Costa, Dominick J Angiolillo, Mark Tannenbaum, et al.
The International Journal of Cardiovascular Imaging|June 2, 2007
Angiographic and 3D intravascular ultrasound assessment of overlapping bare metal stent and three different formulations of drug-eluting stents in patients with diabetes mellitusRen Kawaguchi, Manel Sabate, Dominick J Angiolillo, et al.
International Journal of Cardiology|September 8, 2009
Use of Impella Recover LP 2.5 in elective high risk percutaneous coronary interventionJosé Luis Ferreiro, Joan Antoni Gómez-Hospital, Ángel R Cequier, et al.
Revista Espanola De Cardiologia|December 25, 2004
[Predictors of mortality following rescue percutaneous intervention]Pilar Jiménez-Quevedo, Manel Sabaté, Dominick J Angiolillo, et al.
Journal of the American College of Cardiology|March 13, 2010
Impact of chronic kidney disease on platelet function profiles in diabetes mellitus patients with coronary artery disease taking dual antiplatelet therapyDominick J Angiolillo, Esther Bernardo, Davide Capodanno, et al.
Journal of Cardiovascular Translational Research|December 21, 2013
Impact of cigarette smoking on P2Y12 receptor binding activity before and after clopidogrel therapy in patients with coronary artery diseaseJung Rae Cho, Bhaloo Desai, Michael J Haas, et al.
Journal of the American College of Cardiology|January 17, 2017
Enteric Coating and Aspirin Nonresponsiveness in Patients With Type 2 Diabetes MellitusDeepak L Bhatt, Tilo Grosser, Jing-Fei Dong, et al.
European Heart Journal|January 22, 2011
A pharmacodynamic comparison of prasugrel vs. high-dose clopidogrel in patients with type 2 diabetes mellitus and coronary artery disease: results of the Optimizing anti-Platelet Therapy In diabetes MellitUS (OPTIMUS)-3 TrialDominick J Angiolillo, Juan Jose Badimon, Jorge F Saucedo, et al.
American Heart Journal|January 24, 2007
Anatomical and physiologic assessments in patients with small coronary artery disease: final results of the Physiologic and Anatomical Evaluation Prior to and After Stent Implantation in Small Coronary Vessels (PHANTOM) trialMarco A Costa, Manel Sabate, Rodolfo Staico, et al.
Pageof 76